De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Else Nutrition Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Else Nutrition Holdings heeft een totaal eigen vermogen van CA$1.6M en een totale schuld van CA$2.7M, wat de schuld-eigenvermogensverhouding op 166.5% brengt. De totale activa en totale passiva bedragen respectievelijk CA$12.0M en CA$10.4M.

Belangrijke informatie

166.5%

Verhouding schuld/eigen vermogen

CA$2.68m

Schuld

Rente dekkingsratio	n/a
Contant	CA$841.00k
Aandelen	CA$1.61m
Totaal verplichtingen	CA$10.36m
Totaal activa	CA$11.96m

Recente financiële gezondheidsupdates

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Apr 06

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Aug 15

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Dec 20

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Aug 23

Will Else Nutrition Holdings (TSE:BABY) Spend Its Cash Wisely?

Jan 28

Here's Why We're Watching Else Nutrition Holdings' (CVE:BABY) Cash Burn Situation

Oct 20

Recent updates

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Apr 06

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Aug 15

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Dec 20

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Aug 23

Will Else Nutrition Holdings (TSE:BABY) Spend Its Cash Wisely?

Jan 28

Here's Why We're Watching Else Nutrition Holdings' (CVE:BABY) Cash Burn Situation

Oct 20

We Think Else Nutrition Holdings (CVE:BABY) Can Afford To Drive Business Growth

Jul 13

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CA$11.1M ) BABY } overtreffen de korte termijn passiva ( CA$10.3M ).

Langlopende schulden: De kortetermijnactiva BABY ( CA$11.1M ) overtreffen de langetermijnschulden ( CA$15.0K ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 114.1% ) BABY wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van BABY is de afgelopen 5 jaar gestegen van 2.9% naar 166.5%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: BABY heeft minder dan een jaar aan cash runway op basis van de huidige vrije kasstroom.

Voorspelling contante baan: BABY heeft minder dan een jaar aan kasmiddelen als de vrije kasstroom blijft dalen met historische percentages van 25.4 % per jaar.

Else Nutrition Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Will Else Nutrition Holdings (TSE:BABY) Spend Its Cash Wisely?

Here's Why We're Watching Else Nutrition Holdings' (CVE:BABY) Cash Burn Situation

Recent updates

New major risk - Shareholder dilution

New major risk - Market cap size

Second quarter 2024 earnings released: CA$0.017 loss per share (vs CA$0.032 loss in 2Q 2023)

New minor risk - Share price stability

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of $2 million.

Else Nutrition Holdings Inc. Completes Successful Product Rollout At 308 Locations of Leading Independent Grocery Chain

Else Nutrition Holdings Inc. Completes Rollout of Novel Ready-To-Drink Kids Shakes in 276 Stores of Major Midwest Retailer

Else Nutrition Holdings Inc. Adds New, Ready-To-Drink Kids Shakes At Canada's Largest Grocery Chain

First quarter 2024 earnings released: CA$0.039 loss per share (vs CA$0.07 loss in 1Q 2023)

Insufficient new directors

Else Nutrition Holdings Inc., Annual General Meeting, Jun 12, 2024

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Full year 2023 earnings released: CA$0.13 loss per share (vs CA$0.16 loss in FY 2022)

Else Nutrition Holdings Inc. Launches Ready-To-Drink Kids Shakes on One of Canada's Largest Online Retail Platform

Else Nutrition Holdings Inc. Launches Toddler and Kids Products in over 150 Stores of a Major Retail Chain Providing Potential Access to 2,000 US Stores

Else Announces Online Launch of Its Kids Ready-To-Drink Plant-Powered Shakes with One of Largest Retailers

ELSE NUTRITION HOLDINGS INC. Further Penetrates Canadian Market with Leading Retail Pharmacy Chain Listing of Ready-To-Drink Product

Else Nutrition Holdings Inc. Completes its First Large-Scale Production Run of its Ready-to-Drink Kids Shakes

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 5.005 million.

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 5.005 million.

Else Nutrition Holdings Inc. Launches Full Product Range in the Canadian Retail Locations of One of the World's Largest Retailers of Organic and Natural Foods

Third quarter 2023 earnings released: EPS: CA$0.009 (vs CA$0.032 loss in 3Q 2022)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Else Nutrition Holdings Inc. to Report Q3, 2023 Results on Nov 14, 2023

Else Nutrition Holdings Inc. Announces the Launch of Its Highly Acclaimed, Plant-Based Complete Nutrition Toddler Drink in the United Kingdom

New minor risk - Share price stability

Else Nutrition Holdings Inc.'S Ready-To-Drink Kids Shakes Approved for Sale by Leading Online Marketplace

Else Nutrition Holdings Inc. Announces the Introduction of its First-Ever Ready-To-Drink (Rtd) Kids Nutritional Shakes

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.032 loss per share (vs CA$0.013 loss in 2Q 2022)

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Else Nutrition Holdings Inc. to Report Q2, 2023 Results on Aug 14, 2023

Else Nutrition Holdings Inc. Announces to Launch Its First-Ever Ready-To-Drink (RTD) Products in the Form of Kids Nutritional Shakes in Vanilla and Chocolate Flavors

Else Nutrition Holdings Inc. Achieves Another WIC Approval: Oklahoma Welcomes Kids Shakes and Toddler Nutrition Products

Else Nutrition Holdings Inc.'s Plant-Based Kids Shakes Now Approved by the Arizona Women, Infants, and Children Program

Else Nutrition Holdings Inc. Appoints Yaki Lutski to the Board of Directors

Else Nutrition Holdings Inc. Expands Baby, Toddler, and Kids Nutrition Choices Nationwide

First quarter 2023 earnings released: CA$0.07 loss per share (vs CA$0.069 loss in 1Q 2022)

Else Nutrition Holdings Inc. to Report Q1, 2023 Results on May 15, 2023

Else Nutrition Holdings Inc. Receives IRB Approval for Infant Growth Clinical Study Protocol

Else Nutrition Holdings Inc. announced that it expects to receive $13.75 million in funding from The Lind Partners, LLC

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Third quarter 2022 earnings released: CA$0.032 loss per share (vs CA$0.015 loss in 3Q 2021)

High number of new directors

Else Nutrition Holdings Inc. to Report Q3, 2022 Results on Nov 14, 2022

Else Nutrition Holdings Inc. Kids Products Launch At Retail

Price target increased to CA$4.50

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Second quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.05 loss in 2Q 2021)

Else Nutrition Holdings Inc. to Report Q2, 2022 Results on Aug 15, 2022

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 7.287 million.

Else Nutrition Holdings Inc. Successfully Completes Second Preclinical Study on the Path for FDA Approval

Else Nutrition Holdings Inc. Successfully Completes Second Preclinical Study on the Path for FDA Approval

Vice President of Sales Operations recently sold CA$134k worth of stock

Else Nutrition Holdings Inc. Announces Soy Free Infant Formula in Advance of FDA Approval

Else Nutrition Holdings Inc. Announces Soy Free Infant Formula in Advance of FDA Approval

First quarter 2022 earnings released: CA$0.069 loss per share (vs CA$0.023 profit in 1Q 2021)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Provides Earnings Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Receives Approval for Its Novel Plant-Based Complete Nutrition for Toddlers & Kids to Be Listed At Lassens Natural Food & Vitamins Stores

Else Nutrition Holdings Inc. to Report Q1, 2022 Results on May 16, 2022

Else Nutrition Holdings Inc. Receives Formal Listing Approval for Its Novel

Price target decreased to CA$3.00

High number of new and inexperienced directors

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Releases the First-Ever U.S. Certified Baby Cereal - Safe of Heavy Metals

Else Nutrition Holdings Inc., Annual General Meeting, Jun 30, 2022

Else Nutrition Holdings Inc. Announces That Rouses Markets Has Added Two Additional Products Else Plant-Based Kids Shakes, in Chocolate and Vanilla Flavors

Else Nutrition Holdings Inc. Announces Launch of Else Toddler Nutrition